These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 9143861

  • 1. Metabolic effects of carvedilol in hypertensive patients.
    Lithell H, Andersson PE.
    Eur J Clin Pharmacol; 1997; 52(1):13-7. PubMed ID: 9143861
    [Abstract] [Full Text] [Related]

  • 2. The pharmacokinetics of carvedilol and its metabolites after single and multiple dose oral administration in patients with hypertension and renal insufficiency.
    Gehr TW, Tenero DM, Boyle DA, Qian Y, Sica DA, Shusterman NH.
    Eur J Clin Pharmacol; 1999 Jun; 55(4):269-77. PubMed ID: 10424319
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivity: the carvedilol-metoprolol study.
    Jacob S, Rett K, Wicklmayr M, Agrawal B, Augustin HJ, Dietze GJ.
    J Hypertens; 1996 Apr; 14(4):489-94. PubMed ID: 8761899
    [Abstract] [Full Text] [Related]

  • 6. [Balanced beta--alpha-blocker treatment with carvedilol in mild-moderate arterial hypertension].
    Perocchio M, Gigli G, Barra M, Sacchetti R, Vallebona A, Rosolen GA, Orlandi S.
    Minerva Cardioangiol; 1996 Mar; 44(3):115-21. PubMed ID: 8767610
    [Abstract] [Full Text] [Related]

  • 7. Protective effects of carvedilol, a vasodilating beta-adrenoceptor blocker, against in vivo low density lipoprotein oxidation in essential hypertension.
    Maggi E, Marchesi E, Covini D, Negro C, Perani G, Bellomo G.
    J Cardiovasc Pharmacol; 1996 Apr; 27(4):532-8. PubMed ID: 8847870
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of carvedilol in mild to moderate essential hypertension and effects on microalbuminuria: a multicenter, randomized, open-label, controlled study versus atenolol.
    Marchi F, Ciriello G.
    Adv Ther; 1995 Apr; 12(4):212-21. PubMed ID: 10155349
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the hemodynamic effects of metoprolol and carvedilol in hypertensive patients.
    Weber K, Bohmeke T, van der Does R, Taylor SH.
    Cardiovasc Drugs Ther; 1996 May; 10(2):113-7. PubMed ID: 8842502
    [Abstract] [Full Text] [Related]

  • 10. Carvedilol in hypertension.
    Raftery EB.
    Cardiology; 1993 May; 82 Suppl 3():40-4. PubMed ID: 8106164
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antihypertensive treatment with a vasodilating beta-blocker, carvedilol, in chronic hemodialysis patients.
    Deetjen A, Heidland A, Pangerl A, Meyer-Sabellek W, Schaefer RM.
    Clin Nephrol; 1995 Jan; 43(1):47-52. PubMed ID: 7697935
    [Abstract] [Full Text] [Related]

  • 13. Comparison of a new vasodilating beta-blocker, carvedilol, with atenolol in the treatment of mild to moderate essential hypertension.
    Ruilope LM.
    Am J Hypertens; 1994 Feb; 7(2):129-36. PubMed ID: 7910028
    [Abstract] [Full Text] [Related]

  • 14. Carvedilol.
    Crysant SG.
    Arch Fam Med; 1999 Feb; 8(4):295. PubMed ID: 10418532
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of the antihypertensive effects of carvedilol and metoprolol on resting and exercise blood pressure.
    Franz IW, Agrawal B, Wiewel D, Ketelhut R.
    Clin Investig; 1992 Feb; 70 Suppl 1():S53-7. PubMed ID: 1350485
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the effects of carvedilol and nifedipine in patients with essential hypertension and non-insulin-dependent diabetes mellitus.
    Albergati F, Paternó E, Venuti RP, Boeri D, Lombardo I, Semino S, Viviani GL, Adezati L.
    J Cardiovasc Pharmacol; 1992 Feb; 19 Suppl 1():S86-9. PubMed ID: 1378156
    [Abstract] [Full Text] [Related]

  • 17. Effects of perindopril and carvedilol on endothelium-dependent vascular functions in patients with diabetes and hypertension.
    Giugliano D, Marfella R, Acampora R, Giunta R, Coppola L, D'Onofrio F.
    Diabetes Care; 1998 Apr; 21(4):631-6. PubMed ID: 9571355
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetic and pharmacodynamic comparison of controlled-release carvedilol and immediate-release carvedilol at steady state in patients with hypertension.
    Henderson LS, Tenero DM, Baidoo CA, Campanile AM, Harter AH, Boyle D, Danoff TM.
    Am J Cardiol; 2006 Oct 02; 98(7A):17L-26L. PubMed ID: 17023228
    [Abstract] [Full Text] [Related]

  • 19. Cardioprotective effects of carvedilol, a novel beta adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranolol.
    Bril A, Slivjak M, DiMartino MJ, Feuerstein GZ, Linee P, Poyser RH, Ruffolo RR, Smith EF.
    Cardiovasc Res; 1992 May 02; 26(5):518-25. PubMed ID: 1359930
    [Abstract] [Full Text] [Related]

  • 20. A comparison of carvedilol with atenolol in the treatment of mild-to-moderate essential hypertension. INT-CAR-07 (U.K.) Study Group.
    Young PH.
    J Cardiovasc Pharmacol; 1992 May 02; 19 Suppl 1():S82-5. PubMed ID: 1378155
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.